A network-based approach to visualize prevalence and progression of metabolic syndrome components

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Haring, Robin ^a   Rosvall, Martin ^b   Völker, Uwe ^a   Völzke, Henry ^a   Kroemer, Heyo ^a   Nauck, Matthias ^a   Wallaschofski, Henri ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CENTRAL OBESITY; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FOLLOW UP; GERMANY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PREVALENCE;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84862552287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039461     Document Type: Article

References (43)

1. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, et al. (2007) Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49: 403-414.
2. Sattar N, (2008) Why metabolic syndrome criteria have not made prime time: a view from the clinic. Int J Obes (Lond) 32: S30-34.
3. Sattar N, Forouhi NG, (2005) Metabolic syndrome criteria: ready for clinical prime time or work in progress? Eur Heart J 26: 1249-1251.
4. Grundy SM, (2007) Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92: 399-404.
5. Preiss D, Sattar N, (2009) Metabolic syndrome: collapsing under its own weight? Diabet Med 26: 457-459.
6. Borch-Johnsen K, Wareham N, (2010) The rise and fall of the metabolic syndrome. Diabetologia 53: 597-599.
7. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM, (2004) Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27: 2676-2681.
8. Wannamethee SG, Shaper AG, Lennon L, Morris RW, (2005) Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165: 2644-2650.
9. Qiao Q, (2006) Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 49: 2837-2846.
10. Haring R, Wallaschofski H, Nauck M, Felix SB, Schmidt CO, et al. (2010) Total and cardiovascular disease mortality predicted by metabolic syndrome is inferior relative to its components. Exp Clin Endocrinol Diabetes 118: 685-691.
11. Kahn R, Buse J, Ferrannini E, Stern M, (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289-2304.
12. Scuteri A, Najjar SS, Orru M, Usala G, Piras MG, et al. (2010) The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study. Eur Heart J 31: 602-613.
13. Scuteri A, Morrell CH, Najjar SS, Muller D, Andres R, et al. (2009) Longitudinal paths to the metabolic syndrome: can the incidence of the metabolic syndrome be predicted? The Baltimore Longitudinal Study of Aging. J Gerontol A Biol Sci Med Sci 64: 590-598.
14. Franco OH, Massaro JM, Civil J, Cobain MR, O'Malley B, et al. (2009) Trajectories of entering the metabolic syndrome: the framingham heart study. Circulation 120: 1943-1950.
15. Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, et al. (2011) Cohort profile: the study of health in pomerania. Int J Epidemiol 40: 294-307.
16. Nauck M, Winkler K, Marz W, Wieland H, (1995) Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining. Clin Chem 41: 1761-1767.
17. Haring R, Baumeister SE, Völzke H, Dorr M, Felix SB, et al. (2011) Prospective Association of Low Total Testosterone Concentrations with an Adverse Lipid Profile and Increased Incident Dyslipidemia. Eur J Cardiovasc Prev Rehabil 18: 86-96.
18. Haring R, Wallaschofski H, Nauck M, Dorr M, Baumeister SE, et al. (2009) Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 50: 1403-1411.
19. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
20. Hannemann A, Meisinger C, Bidlingmaier M, Doring A, Thorand B, et al. (2011) Association of plasma aldosterone with the metabolic syndrome in two German populations. Eur J Endocrinol 164: 751-758.
21. Schipf S, Alte D, Voelzke H, Friedrich N, Haring R, et al. (2010) Prävalenz des Metabolischen Syndroms in Deutschland: Ergebnisse der Study of Health in Pomerania (SHIP). Diabetologie & Stoffwechsel 5: 161-168.
22. Lidfeldt J, Nyberg P, Nerbrand C, Samsioe G, Schersten B, et al. (2003) Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes Obes Metab 5: 106-112.
23. Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB, (2008) Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab 93: 3403-3410.
24. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW, (2005) Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 54: 3252-3257.
25. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB, (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112: 3066-3072.
26. Qiao Q, Laatikainen T, Zethelius B, Stegmayr B, Eliasson M, et al. (2009) Comparison of definitions of metabolic syndrome in relation to the risk of developing stroke and coronary heart disease in Finnish and Swedish cohorts. Stroke 40: 337-343.
27. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, et al. (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110: 1245-1250.
28. Shulman GI, (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176.
29. Gortmaker SL, Swinburn BA, Levy D, Carter R, Mabry PL, et al. (2011) Changing the future of obesity: science, policy, and action. Lancet 378: 838-847.
30. Grundy SM, (2004) Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89: 2595-2600.
31. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952.
32. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, et al. (2007) Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation 115: 1067-1074.
33. Nagaretani H, Nakamura T, Funahashi T, Kotani K, Miyanaga M, et al. (2001) Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. Diabetes Care 24: 2127-2133.
34. Ford ES, Giles WH, Mokdad AH, (2004) Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care 27: 2444-2449.
35. Chimonas T, Karagiannis A, Athyros VG, Achimastos A, Elisaf M, et al. (2010) Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysis. Metab Syndr Relat Disord 8: 523-529.
36. Meisinger C, Heier M, Volzke H, Lowel H, Mitusch R, et al. (2006) Regional disparities of hypertension prevalence and management within Germany. J Hypertens 24: 293-299.
37. Tuomilehto J, Schwarz P, Lindstrom J, (2011) Long-term benefits from lifestyle interventions for type 2 diabetes prevention: time to expand the efforts. Diabetes Care 34: S210-214.
38. Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN, (2005) Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care 28: 391-397.
39. Haring R, Volzke H, Felix SB, Schipf S, Dorr M, et al. (2009) Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes 58: 2027-2031.
40. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA, (2007) Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 7: 220.
41. Haring R, Wallaschofski H, (2012) Diving through the "-omics": the case for deep phenotyping and systems epidemiology. OMICS 16: 231-234.
42. Barabasi AL, (2007) Network medicine-from obesity to the "diseasome" N Engl J Med 357: 404-407.
43. Barabasi AL, Gulbahce N, Loscalzo J, (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12: 56-68.